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Background
Continuous Glucose Monitors (CGMs)
The CGM consists of a pager-like monitoring device that receives information from a sensor inserted 
under the skin that detects glucose in the interstitial fluid.
• Originally designed to help Type 1 diabetics manage blood glucose levels 
• Recently used in the Intensive Care Unit (ICU) and  Neonatal Intensive Care Unit (NICU) to detect 
hypoglycaemia in at-risk babies
• CGM accuracy is dependent on Blood Glucose (BG) calibration measurements entered into the device  
every four times a day
• Much more frequent measure of blood glucose (5 minutely) but performance trade offs   
(www.medtronic.com)






















Optimisation of an athlete’s BG  has the potential to
 Increase race performance – knowing when and what to eat during racing
 Speed recovery – Optimal replacement of glycogen stores 
 Aid training - as blood glucose can reflect metabolic and inflammatory conditions  
However, before these benefits can be realized the accuracy and 
performance of CGM devices in active athletes must be evaluated



























A Re-calibration algorithm was used to make better use of 
the accurate blood glucose measurements.
Background
Linear Regression Calibration
The CGM uses linear regression techniques combined 
with smoothing. This is a typical “built-in” method of 
calibration.
Blood Glucose = slope * (electric current- offset)


























Re-calibrated CGM Trace 
passes through BG 
calibration measurements
Original CGM Trace 
passes near BG 
calibration measurements
Recalibration of CGM data
Procedure
Two fasting exercise tests were carried out 3 days apart:
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𝑂𝑓𝑓𝑠𝑒𝑡 = 𝐶𝐺𝑀 − 𝐵𝐺
Mean absolute relative difference (MARD) and Offset was calculated between 
reference BG measurements collected during the fasting tests and the CGM trace:
These metrics were assessed during: 
 the exercise or sedentary phase only (0 – 120mins)







Results – Exercise Performance 
During Exercise MARD are equivalent if not better than the performance reported for CGM in
diabetic subjects – 10.8 [8.7 – 16.7] % median [IQR] or 7.3 [5.4 – 10.9] % with recalibration
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Exercise Fasting Test 1 Exercise Fasting Test 2 
Results – Sedentary Performance
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Exercise Fasting Test 1 Exercise Fasting Test 2 
Sedentary tests obtained worse performance attributed to two main
factors:
• The reference measurements most likely biased during the sedentary
test due to low apparent skin and leading to BG meters reading lower
than expected values
• Interstitial fluid is not actively pumped like blood. It relies on muscle
movement to circulate and mix.
Result - Bias
 There is a consistent positive bias evident, whether it 
be exercising or sedentary, or when applying the 
recalibration algorithm or the factory algorithm. 
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The small data set is a major limitation
of this study, however:
Based on the results of this study an Athlete trial plan
was formed to further test the performance of CGM
devices:
 10 fit, healthy adults with a resting heart rate of 60 
beats per minute (bpm) or lower 
 Participants will have 2 Ipro2 CGM devices 
(Medtronic Minimed, Northridge, CA, USA) inserted 
in to their abdomen at least 24 hours before 
undertaking an exercise test 
Protocol





























 8/10 Subjects enrolled so far
 Very similar performance between recalibration algorithm and factory algorithm 
 Very good performance across the board.  
 Offset no longer evident 
MARD SG1 SG2 SG1 recal SG 2 recal Median[IQR]
ATH01 11.2 13.4 32.5 12.4 12.9 [11-28]
ATH02 15.2 14.9 9.3 11.5 13.2 [9.8-15]
ATH03 9.0 8.9 6.8 7.7 8.3 [7.0-9.0] 
ATH04 12.3 13.8 13.0
ATH05 13.8 11.9 10.8 11.3 11.6 [11-13]
ATH06 12.7 13.8 15.7 17.3 14.8 [13-17]
ATH07 11.1 32.3 22.4 17.9 20.2 [13-30]
ATH08 10.6 14.2 7.5 16.0 12.4 [8.3-16]
Median [IQR] 11.8 [11-14] 13.8 [12-15] 12.3 [7.9-21] 12.4 [11-17]
Conclusions
 Good Performance seen with CGM during exercise - Sensors agree well with each other and  
reference measurements 
 During sedentary periods the accuracy of the monitors was reduced - This decrease in 
accuracy is likely related to the fact interstitial fluid is not actively pumped like blood. It relies 
on muscle movement to circulate and mix. 
 These result show real promise for using CGM to help optimize BG levels in an athletic 
active cohort
 These differences in performance also provide insight into how these devices might be more 
optimally used in the target, more sedentary cohort. 
Future work 
 Develop Athlete Specific Metabolic Model:
 Create Endogenous insulin secretion Model 
 Create Endogenous glucose production Model 
 Examine the sensitivity of SI to change in other glucose metabolism parameters
 Develop a protocol to optimise Athletes Blood Glucose using 
CGM values
 Develop robust control methods to modelled variation and CGM dynamics
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